Skip to main content
Premium Trial:

Request an Annual Quote

Georgetown University Taps Ariadne's Pathway Studio for Cancer Translational Research

Premium

Ariadne said this week that Georgetown University has taken a site license for its Pathway Studio software to assist in cancer research efforts, as well as to enable investigators to share their research findings via the Georgetown Database of Cancer, or G-DOC, initiative.

Pathway Studio allows researchers to mine, integrate, analyze, and visualize results individually or as an integrated workflow. Each step can be saved and then updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.

Ilya Mazo, president of Ariadne, said that his firm's "expertise in developing biological knowledgebases for disease modeling fits nicely into Georgetown Lombardi's vision and goals."

In a statement, Subha Madhavan, director of clinical research informatics at Georgetown Lombardi, highlighted the importance of translational medicine as an "investigative tool" for identifying "biomarkers and surrogate markers involved with disease or therapeutic response."

In particular, she said that GU was seeking tools "that can help integrate published findings with our microRNA experimental data."

Georgetown University's Lombardi Comprehensive Cancer Center launched G-DOC last October to provide a repository of cancer information and tools. At the time of the launch, G-DOC contained genomics, proteomics, metabolomics, methylomics, and transcriptomics data from tumors, as well as clinical treatment and outcome information, for about 2,953 breast cancer patients.

The web-based platform includes a genome viewer that let users visualize multiple data types and supports flexible clinical criteria browsing to enable specific cohort selection and generate detailed reports, among other features (BI 10/03/2011).

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.